In fact, loss-of-function (LOF) alterations in NLRC5 and CIITA were consistent with the loss of MHC class I and class II expression in NPC tumor cells (Fig. 4B and Supplementary figure 6). The gene discussed is CIITA; the disease is nasopharyngeal carcinoma.